Novartis AG's former pharmaceuticals head has joined a biotech-focused venture-capital firm, in what is becoming a well-trodden path for drug-industry bosses. David Epstein, who departed Novartis last year amid a shake-up of the Swiss drug giant's pharmaceuticals division, is to join Cambridge, Mass.-based venture firm Flagship Pioneering.